MedTech's affinity groups are networks of members with common interests that meet to share experiences and learn from each other. Any member is welcome to join an affinity group at any time. For more information contact Sarah at email@example.com.
Regulatory Affairs & Quality Systems Affinity Group
The Regulatory Affairs & Quality Systems affinity group (RA-QS) consists of regulatory and quality professionals focused on the quality principles and regulatory issues affecting today’s rapidly changing global medical device, pharmaceutical and biotechnology companies. In partnership with MedTech, RA-QS facilitates related networking and events through training, education and industry knowledge that help professionals advance themselves and their companies.
Manufacturing & Operations Affinity Group
The Operations & Manufacturing affinity group (O&M) works to enable networks, tools and programs that facilitate best practice sharing and collaboration among operations and manufacturing professionals within MedTech member organizations. O&M facilitates connectivity among member organizations by creating opportunities for training, group panels, plant visits and more.
Clinical Research Affinity Group
The Clinical Research affinity group (CRA) is comprised of clinical research professionals that meet to share best practices, industry knowledge and clinical trial issues related to product approval requirements in the medical device, pharmaceutical and biotech industries. CRA collaborates with industry colleagues to identify and plan related education and certification opportunities.
Workforce Development Affinity Group
The Workforce Development affinity group (WDA) was formed in response to MedTech’s 2014 industry publication “Bio/Med Breakthroughs”. The report provides a comprehensive snapshot of the industry’s economic impact and growth potential in New York with a primary focus on Upstate New York. It also includes a regional assessment of the industry’s workforce and talent base. WDA consists of human resource and recruitment professionals and representatives from academia focused on addressing the workforce challenges identified by our study. The group also facilitates the sharing of best practices and identifies programming to help sustain the Bio/Med industry’s talent pipeline in New York State.